- Home
- AKAN vs PRFX Comparison
AKAN vs PRFX Comparison
Compare AKAN & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKAN | PRFX |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.8M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AKAN | PRFX |
|---|---|---|
| Price | $0.97 | $0.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 69.1K |
| Earning Date | 12-16-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $836,664.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 183.67 | N/A |
| 52 Week Low | $0.85 | $0.80 |
| 52 Week High | $9.29 | $16.63 |
Technical Indicators
Market Signals| Indicator | AKAN | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 30.59 | 45.94 |
| Support Level | $0.93 | $0.91 |
| Resistance Level | $1.04 | $0.98 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 24.47 | 39.02 |
Price Performance
Historical ComparisonAbout AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.